阿司匹林预防子痫前期对胎盘早剥和产前出血影响的荟萃分析
该系统评价与荟萃分析纳入20项随机对照试验共12585名参与者,评估阿司匹林预防子痫前期时对胎盘早剥或产前出血的影响。按每日剂量(<100 mg与≥100 mg)和用药起始孕周(≤16周与>16周)分层分析。结果显示,每日≥100 mg且起始于≤16周孕周时,阿司匹林可能降低胎盘早剥或产前出血风险,但亚组间差异显著(P=.04)。
要点
- 每日<100 mg阿司匹林对胎盘早剥或产前出血风险无影响,无论起始于≤16周还是>16周。
- 每日≥100 mg且起始于≤16周时,阿司匹林可能与胎盘早剥或产前出血风险降低相关(RR 0.62,95%CI 0.31-1.26)。
- 每日≥100 mg且起始于>16周时,阿司匹林与胎盘早剥或产前出血风险无显著关联(RR 2.08,95%CI 0.86-5.06),但亚组间差异显著(P=.04)。
核心结论
- 每日剂量≥100 mg的阿司匹林用于预防子痫前期且起始于≤16周孕周而非>16周时,可能降低胎盘早剥或产前出血风险。
研究设计与样本
- 系统评价与荟萃分析,纳入20项随机对照试验,共12585名参与者,检索PubMed、Cinhal、Embase、Web of Science和Cochrane library(1985年至2017年9月)。
主要发现
- 每日<100 mg阿司匹林起始于≤16周时,胎盘早剥或产前出血的相对风险为1.11(95%CI 0.52-2.36)。
- 每日<100 mg阿司匹林起始于>16周时,相对风险为1.32(95%CI 0.73-2.39)。
- 每日≥100 mg阿司匹林起始于≤16周时,相对风险为0.62(95%CI 0.31-1.26)。
- 每日≥100 mg阿司匹林起始于>16周时,相对风险为2.08(95%CI 0.86-5.06)。
- 每日≥100 mg阿司匹林起始于≤16周与>16周两个亚组之间的差异显著(P=.04)。
关键数值与推荐
- 每日<100 mg阿司匹林对胎盘早剥或产前出血风险无影响,无论起始于≤16周(RR 1.11,95%CI 0.52-2.36)还是>16周(RR 1.32,95%CI 0.73-2.39)。
- 每日≥100 mg阿司匹林起始于≤16周时与胎盘早剥或产前出血风险无显著关联(RR 0.62,95%CI 0.31-1.26)。
- 每日≥100 mg阿司匹林起始于>16周时与胎盘早剥或产前出血风险无显著关联(RR 2.08,95%CI 0.86-5.06)。
- 每日≥100 mg阿司匹林起始于≤16周与>16周两个亚组之间的差异显著(P=.04)。
临床怎么用
- 原文结论指出,每日剂量≥100 mg的阿司匹林用于预防子痫前期且起始于≤16周孕周而非>16周时,可能降低胎盘早剥或产前出血风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE DATA: Impaired placentation in the first 16 weeks of pregnancy is associated with increased risk of subsequent development of preeclampsia, birth of small-for-gestational-age neonates, and placental abruption. Previous studies reported that prophylactic use of aspirin reduces the risk of preeclampsia and small-for-gestational-age neonates with no significant effect on placental abruption. However, meta-analyses of randomized controlled trials that examined the effect of aspirin in relation to gestational age at onset of therapy and dosage of the drug reported that significant reduction in the risk of preeclampsia and small-for-gestational-age neonates is achieved only if the onset of treatment is at ≤16 weeks of gestation and the daily dosage of the drug is ≥100 mg. STUDY: We aimed to estimate the effect of aspirin on the risk of placental abruption or antepartum hemorrhage in relation to gestational age at onset of therapy and the dosage of the drug. STUDY APPRAISAL AND SYNTHESIS METHODS: To perform a systematic review and meta-analysis of randomized controlled trials that evaluated the prophylactic effect of aspirin during pregnancy, we used PubMed, Cinhal, Embase, Web of Science and Cochrane library from 1985 to September 2017. Relative risks of placental abruption or antepartum hemorrhage with their 95% confidence intervals were calculated with the use of random effect models. Analyses were stratified according to daily dose of aspirin (<100 and ≥100 mg) and the gestational age at the onset of therapy (≤16 and >16 weeks of gestation) and compared with the use of subgroup difference analysis. RESULTS: The entry criteria were fulfilled by 20 studies on a combined total of 12,585 participants. Aspirin at a dose of <100 mg per day had no impact on the risk of placental abruption or antepartum hemorrhage, irrespective of whether it was initiated at ≤16 weeks of gestation (relative risk, 1.11; 95% confidence interval, 0.52-2.36) or at >16 weeks of gestation (relative risk, 1.32; 95% confidence interval, 0.73-2.39). At ≥100 mg per day, aspirin was not associated with a significant change on the risk of placental abruption or antepartum hemorrhage, whether the treatment was initiated at ≤16 weeks of gestation (relative risk, 0.62, 95% confidence interval, 0.31-1.26), or at >16 weeks of gestation (relative risk, 2.08; 95% confidence interval, 0.86-5.06), but the difference between the subgroups was significant (P=.04). CONCLUSION: Aspirin at a daily dose of ≥100 mg for prevention of preeclampsia that is initiated at ≤16 weeks of gestation, rather than >16 weeks, may decrease the risk of placental abruption or antepartum hemorrhage.
引用
- Roberge S, Bujold E, Nicolaides KH, et al. Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage. Am J Obstet Gynecol. 2018. PMID: 29305829. doi:10.1016/j.ajog.2017.12.238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。